The fight against tuberculosis is the latest effort to investigate innovative financing instruments for vital funding. The Global Fund to Fight AIDS, Tuberculosis and Malaria and the International Union against Tuberculosis and Lung Disease (The Union) recently announced a new partnership to spur investment among the private sector to help end the TB epidemic by 2030.

Efforts to combat TB have been hampered by a lack of new diagnostic tools, a lack of investment, and increasing multiple-drug resistance.

Missing cases are another growing concern. Every year 10.4 million people get sick with TB, 40 percent of whom are never diagnosed or treated. In response, the Global Fund, along with partners including the World Health Organization and Stop TB Partnership, also launched a new “catalytic funding” program to find and treat an additional 1.5 million “missing” people with TB in 13 high-burden countries by 2019. The catalytic funding for TB seeks to support innovative programs, promote better use of data, and expand successful approaches.

Read the full article on TB and innovative finance by Sophie Cousins at Devex International Development